Correspondence to editorial 1 on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial". - Lee SH; Yim SY; Kim JH; Lee SS; Kaseb AO; Lee JS (Clinical and molecular hepatology, 2025)